{
  "brief": "tvm",
  "title": "TVM Market Brief: Signed-Case Cost and Statute Posture",
  "publisher": "Mass Tort Ad Agency",
  "url": "https://masstortadagency.com/tort-brief/tvm",
  "posture": "No MDL on file. Statute posture is the gate.",
  "venue": "No federal MDL on file. State-court and individual filing posture.",
  "computed_at": "2026-08-24 08:06:07",
  "generated_at": "2026-08-25T00:09:14.864Z",
  "disclaimer": "Acquisition figures are computed from MTAA-managed Meta campaign delivery over trailing windows and change daily. Sample sizes are small; treat as directional. Figures are managed-account results, not a market-wide index, and not a price quote.",
  "acquisition": [
    {
      "track": "Sub-$1K signed case",
      "tort_slug": "tvm",
      "is_primary": true,
      "mdl_number": null,
      "status": "live",
      "windows": [
        {
          "window_days": 7,
          "spend": 0,
          "leads": 0,
          "signed": 0,
          "cpl": null,
          "cpsc": null,
          "qualifying_campaigns": 0,
          "has_signed_data": false
        },
        {
          "window_days": 30,
          "spend": 0,
          "leads": 0,
          "signed": 0,
          "cpl": null,
          "cpsc": null,
          "qualifying_campaigns": 0,
          "has_signed_data": false
        }
      ]
    }
  ],
  "docket": [],
  "pending_actions": [],
  "velocity": null,
  "risks": [
    {
      "h": "Statute erosion",
      "p": "This is an aging claimant population. If a firm's screening does not rigorously apply the discovery rule, a large share of signed cases can turn out to be time-barred on workup, converting cheap signed cases into expensive write-offs."
    },
    {
      "h": "Product identification failure",
      "p": "Many claimants cannot name their device, and hospitals purge records. If operative reports cannot be retrieved or do not identify the manufacturer, the claim is unworkable regardless of injury severity, and retrieval failure rates directly inflate the true cost per usable case."
    },
    {
      "h": "No consolidation to ride",
      "p": "With no federal MDL on file, there is no common-benefit workup, no bellwether pressure, and no global settlement mechanism to lean on. Each case has to be litigated or resolved individually, which raises per-case cost and favors firms with existing mesh litigation infrastructure."
    },
    {
      "h": "Previously settled claimants in the lead flow",
      "p": "A mature tort attracts claimants who already resolved claims in earlier waves. If intake does not screen for prior releases, the signed book will carry dead inventory that only surfaces at referral or workup."
    }
  ],
  "faq": [
    {
      "q": "Is there an MDL for TVM?",
      "a": "Not on file for this tort. Firms should assume a state-court or individual-filing posture and should not plan around a consolidated federal docket, bellwether schedule, or census process."
    },
    {
      "q": "What does a signed TVM case cost right now?",
      "a": "Over the trailing 30 days on MTAA-managed Meta delivery, the cost per signed case is running under $1,000, with roughly one retainer per fourteen leads from a single qualifying campaign. Seven-day cost per lead is slightly below the 30-day figure."
    },
    {
      "q": "What is the strongest injury profile?",
      "a": "A claimant with a documented revision or removal surgery, an operative report identifying the mesh product and manufacturer, and a recent diagnosis or revision date that supports a discovery-rule statute argument."
    },
    {
      "q": "What disqualifies a lead most often?",
      "a": "Three things: inability to identify or retrieve records naming the product and manufacturer, a statute-barred timeline with no discovery-rule support, and a prior settled or released mesh claim."
    },
    {
      "q": "Should a firm without mesh experience enter this tort?",
      "a": "It depends on the firm's risk appetite and infrastructure. Without a consolidated docket, cases must be worked individually. Firms without records-retrieval capacity and a state-court litigation plan should either partner with one that has both or pass."
    },
    {
      "q": "What should we watch to gauge whether this market is growing or closing?",
      "a": "The desk does not publish a filing count for TVM. Watch state-court filing activity, retrieval success rates in your own signed book, and the share of leads presenting with recent revision surgeries — that last figure is the best proxy for how much statute-viable inventory remains."
    }
  ]
}